Inhibition of peptide BF-30 on influenza A virus infection in vitro/vivo by causing virion membrane fusion.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jun,Xu

第一单位： School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: 675454514@qq.com.

作者： Jun,Xu ^[1] ; Shuo,Chen ^[2] ; Jing,Jin ^[3] ; Lingman,Ma ^[4] ; Min,Guo ^[5] ; Changlin,Zhou ^[6] ; Jie,Dou ^[7]

作者单位： School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: 675454514@qq.com. ^[1] School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: 1220018125@qq.com. ^[2] School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: 435241872@qq.com. ^[3] School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: malingman1987@126.com. ^[4] School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: 1020152471@cpu.edu.cn. ^[5] School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: cl_zhou@cpu.edu.cn. ^[6] School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: doujie@cpu.edu.cn. ^[7]

关键词 Antiviral activity Influenza A virus Oseltamivir-resistant Peptide BF-30 Virion membrane fusion